Go Pro
NASDAQ:CUPR

Cuprina Holdings (Cayman) Q4 2025 Earnings Report

Cuprina Holdings (Cayman) logo
$1.88 -0.11 (-5.53%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$1.94 +0.06 (+3.14%)
As of 05:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cuprina Holdings (Cayman) EPS Results

Actual EPS
-$0.40
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cuprina Holdings (Cayman) Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cuprina Holdings (Cayman) Announcement Details

Quarter
Q4 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cuprina Holdings (Cayman) Earnings Headlines

A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
Cuprina Prices 4.32 Mln Share Offering At $1.15/shr
See More Cuprina Holdings (Cayman) Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cuprina Holdings (Cayman)? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cuprina Holdings (Cayman) and other key companies, straight to your email.

About Cuprina Holdings (Cayman)

Cuprina Holdings (Cayman) (NASDAQ:CUPR) Limited is a healthcare company focused on the development and commercialization of wound-care products. The company operates through subsidiaries and is associated with the Cuprina brand of medical products.

Cuprina’s business centers on wound-management solutions, including products designed to support the treatment and healing of wounds. Its offerings are based in part on medical-grade honey and other naturally derived ingredients used in wound-care applications.

The company has roots in Singapore and serves the healthcare market through activities that include product development, regulatory work, commercialization, and distribution. Publicly available information about its broader geographic operations and leadership is limited.

View Cuprina Holdings (Cayman) Profile